“…A long list of adverse outcomes and malformations have been reported with the use of amphetamine or meth during pregnancy, including cleft lip (Little, Snell & Gilstrap 1988;Schneider & Norton 1979;Milkovich & van der Berg 1977;Nelson & Forfar 1971), cardiac defects (Little, Snell & Gilstrap 1988;Nelson & Forfar 1971;Nora et al 1970;Nora, McNamara & Fraser 1967), low birth weight (Little, Snell & Gilstrap 1988;Oro & Dixon 1987), growth reduction (Smith et al , 2003Chomchai et al 2004;Little, Snell & Gilstrap 1988;Oro & Dixon 1987;Eriksson, Larsson & Zetterstrom 1981 ), reduced head circumference (Chomchai et al 2004;Little, Snell & Gilstrap 1988;Oro & Dixon 1987;Eriksson, Larsson & Zetterstrom 1981), prematurity (Eriksson et al 1978), stillbirth (Eriksson et al 1978), hyperbilirubinemia requiring exchange transfusion (Eriksson et al 1978), cere bral hemorrhage (Dixon & Bejar 1989), low body fat (Little et al 1988), Mongolian spots (Little, Snell & Gilstrap 1988), systolic murmur (Little, Snell & Gilstrap 1988) and unde scended testes (Little, Snell & Gilstrap 1988). A recently published study, which examined 17 -year data from the Hawaii birth defects registry, reported significantly higher than expected rates for maternal prenatal use of meth, co caine, and marijuana among children born with birth defects affecting the central nervous system, cardiovascular system, oral clefts, and limbs (Forrester & Merz 2007).…”